Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Drug-resistant seizures often take years to develop

28.01.2003


While about 80 percent of people with epilepsy gain significant relief from drug therapy, the remaining 20 percent have seizures that cannot be controlled by medications. Many of these people have a particular type of epilepsy called partial epilepsy. A new study shows that people with partial epilepsy often have seizures controlled by medications for years before their seizures become drug-resistant. The study also found that periods when seizures stopped for a year or more are common in these patients.



"This study opens the door for early identification of patients who will later develop drug-resistant partial epilepsy, which may in turn allow us to identify ways of preventing some forms of epilepsy from ever becoming drug-resistant," says lead author Anne T. Berg, Ph.D., of Northern Illinois University in DeKalb, who is part of a large multicenter team directed by Susan Spencer, M.D., at Yale University in New Haven, Connecticut. The study was funded by the National Institute of Neurological Disorders and Stroke (NINDS) and appears in the January 28, 2003, issue of Neurology.*

In the new study, researchers looked at patients who had surgery for drug-resistant partial epilepsy to identify factors that predict when seizures will become intractable, or no longer controllable with medications. They also studied the incidence of previous seizure-free periods in this group. Partial epilepsy results from abnormal neuronal activity that originates in a single part of the brain, usually in one of the temporal lobes.


Epilepsy is a disorder in which clusters of nerve cells, or neurons, in the brain display patterns of abnormal activity. This activity can cause a variety of symptoms, including convulsions. Physicians have described dozens of different kinds of epilepsy. "Epilepsy is not a single disorder – like cancer, it’s a multitude of disorders with varying symptoms, prognoses, and implications for specific treatment," says Dr. Berg. Partial epilepsy accounts for about 40-50 percent of childhood epilepsy and 90 percent of adult-onset epilepsy, she adds. Other types of epilepsy result from abnormal neuronal activity in many parts of the brain.

In this study, researchers looked at 333 patients who had undergone surgery for partial seizures and who were part of a larger ongoing study to examine the outcomes of epilepsy surgery. Most of these patients had temporal lobe epilepsy, or TLE. The researchers examined medical records and conducted structured interviews with these patients to determine the duration, frequency, and types of seizures the patients experienced. They found that patients’ average age when they had their first seizure was 14.6 years, while the average age at which they underwent surgery was 36.7 years. The 282 patients for whom historical data were available had been diagnosed with epilepsy an average of 9 years before their epilepsy became intractable. Intractable epilepsy in this study was defined as a failure of two medications to control seizures.

The researchers also asked about periods when the patients had been seizure-free. About one quarter of the patients said they had been seizure-free for a year or more. Twenty-four patients (8.5 percent) were seizure-free for 5 years or more. A seizure-free period of 1 year or longer was most common in people who were younger than 5 when they were diagnosed. The results show that a history of seizure-free periods is common in people who later develop intractable seizures.

The study identified several factors that were related to the amount of time before seizures became intractable. These factors included age of onset, type of surgery the patients received, history of febrile (fever-related) seizures, and atrophy of the hippocampus, the region of the brain that is affected in TLE. Of these factors, age of onset had the strongest relationship with the amount of time until intractability, Dr. Berg says. In patients whose seizures began before age 5, it took an average of 15 years for their seizures to become intractable. In patients whose epilepsy began during their 30s and 40s, however, seizures tended to become intractable immediately or within only a few years.

"Consistent with other reports, many individuals in our study did indeed have epilepsy that became intractable within a short time after its initial onset. What is startling, however, is the large number of patients who experienced prolonged periods of seizure control before their seizures became intractable," Dr. Berg says. Based on the 15-year average time it took for early-onset seizures to become intractable, Dr. Berg says that studies of epilepsy prognosis need to proceed for at least that amount of time in order to identify patients who might develop intractable seizures late in the course of the disorder.

The results of this study pertain only to partial epilepsy, primarily TLE, and cannot and should not be generalized to other forms of epilepsy, Dr. Berg notes.

"These data give us some clues, but they only begin to scratch the surface. We need careful, prospective long-term studies in order to accurately understand the long-term prognosis of partial epilepsy," says Dr. Berg. She and her colleagues are now conducting additional studies to determine which patients develop intractable seizures.


The NINDS is a component of the National Institutes of Health, within the U.S. Department of Health and Human Services, and is the nation’s primary supporter of biomedical research on the brain and nervous system.

*Berg AT, Langfitt J, Shinnar S, Vickrey BG, Sperling MR, Walczak T, Bazil C, Pacia SV, Spencer SS, for the Multicenter Study of Epilepsy Surgery. "How long does it take for partial epilepsy to become intractable?" Neurology, January 28, 2003, vol. 60, pp. 186-190.

Tania Zeigler | EurekAlert!
Further information:
http://www.ninds.nih.gov/

More articles from Health and Medicine:

nachricht New malaria analysis method reveals disease severity in minutes
14.08.2017 | University of British Columbia

nachricht New type of blood cells work as indicators of autoimmunity
14.08.2017 | Instituto de Medicina Molecular

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Fizzy soda water could be key to clean manufacture of flat wonder material: Graphene

Whether you call it effervescent, fizzy, or sparkling, carbonated water is making a comeback as a beverage. Aside from quenching thirst, researchers at the University of Illinois at Urbana-Champaign have discovered a new use for these "bubbly" concoctions that will have major impact on the manufacturer of the world's thinnest, flattest, and one most useful materials -- graphene.

As graphene's popularity grows as an advanced "wonder" material, the speed and quality at which it can be manufactured will be paramount. With that in mind,...

Im Focus: Exotic quantum states made from light: Physicists create optical “wells” for a super-photon

Physicists at the University of Bonn have managed to create optical hollows and more complex patterns into which the light of a Bose-Einstein condensate flows. The creation of such highly low-loss structures for light is a prerequisite for complex light circuits, such as for quantum information processing for a new generation of computers. The researchers are now presenting their results in the journal Nature Photonics.

Light particles (photons) occur as tiny, indivisible portions. Many thousands of these light portions can be merged to form a single super-photon if they are...

Im Focus: Circular RNA linked to brain function

For the first time, scientists have shown that circular RNA is linked to brain function. When a RNA molecule called Cdr1as was deleted from the genome of mice, the animals had problems filtering out unnecessary information – like patients suffering from neuropsychiatric disorders.

While hundreds of circular RNAs (circRNAs) are abundant in mammalian brains, one big question has remained unanswered: What are they actually good for? In the...

Im Focus: RAVAN CubeSat measures Earth's outgoing energy

An experimental small satellite has successfully collected and delivered data on a key measurement for predicting changes in Earth's climate.

The Radiometer Assessment using Vertically Aligned Nanotubes (RAVAN) CubeSat was launched into low-Earth orbit on Nov. 11, 2016, in order to test new...

Im Focus: Scientists shine new light on the “other high temperature superconductor”

A study led by scientists of the Max Planck Institute for the Structure and Dynamics of Matter (MPSD) at the Center for Free-Electron Laser Science in Hamburg presents evidence of the coexistence of superconductivity and “charge-density-waves” in compounds of the poorly-studied family of bismuthates. This observation opens up new perspectives for a deeper understanding of the phenomenon of high-temperature superconductivity, a topic which is at the core of condensed matter research since more than 30 years. The paper by Nicoletti et al has been published in the PNAS.

Since the beginning of the 20th century, superconductivity had been observed in some metals at temperatures only a few degrees above the absolute zero (minus...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Call for Papers – ICNFT 2018, 5th International Conference on New Forming Technology

16.08.2017 | Event News

Sustainability is the business model of tomorrow

04.08.2017 | Event News

Clash of Realities 2017: Registration now open. International Conference at TH Köln

26.07.2017 | Event News

 
Latest News

A Map of the Cell’s Power Station

18.08.2017 | Life Sciences

Engineering team images tiny quasicrystals as they form

18.08.2017 | Physics and Astronomy

Researchers printed graphene-like materials with inkjet

18.08.2017 | Materials Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>